PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Medicine, QU Health, Qatar University, Doha, Qatar.\', \'Faculty of Medicine, Eastern Mediterranean University, Famagusta, North Cyprus.\', \'Division of Internal Medicine, Hamad Medical Corporation Hospital, Doha, Qatar.\', \'School of Applied Sciences, University of Huddersfield, Huddersfield, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/1061186X.2020.1797754
?:hasPublicationType
?:journal
  • Journal of drug targeting
is ?:pmid of
?:pmid
?:pmid
  • 32700580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.851
?:rankingScore_hIndex
  • 77
is ?:relation_isRelatedTo_publication of
?:title
  • Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety.
?:type

Metadata

Anon_0  
expand all